Relation Therapeutics expands GSK AI drug discovery deal worth up to $110M
anshulkundaje · x · 2026-07-31
AI biotech firm Relation Therapeutics announced an expanded collaboration with pharmaceutical giant GSK. The partnership will deploy Relation's flagship cellular foundation model, MORGAN, at a new scale. The deal includes upfront and success-based milestone payments totaling up to $110 million.
More from Companies & People
- Google Requires UX Designers to be 'Fluent in AI', Exploring Workflow Integration — Sea-Masterpiece-8496 · 2026-07-31
- Microsoft's AI Pivot: Accelerating Office Growth Shatters Low Valuation Narrative — BenBajarin · 2026-07-31
- Wall Street's Impatience Clashes with AI Drug Discovery Timelines — marigo · 2026-07-31
- Anthropic Hires Former OpenAI Safety Researcher Leopold Aschenbrenner — PtrPomorski · 2026-07-31
- Head of AI Roles Tripled in 9 Months, 69% from Non-Tech Sectors — vilnitskiy · 2026-07-31
- ByteDance Merges Feishu and Doubao Teams; Weng Li Returns to OpenAI — 创业邦 · 2026-07-31